Skip to main content
The Science of Small Chains

Peptide Therapy,
Explained.

Peptides are short chains of amino acids - the body's own signaling molecules. In therapeutic use, they instruct cells to repair tissue, regulate hormones, reduce inflammation, and optimize metabolic function.

Peptidely translates cutting-edge research into clear, evidence-graded information for patients, practitioners, and researchers.

Evidence-graded · Practitioner-reviewed · Updated regularly

Most Researched

Trending Peptides

Browse Profiles →

Start with the compounds people most often compare first, then drill into the full profile only when you need mechanism and protocol detail.

Metabolic Health
Trending FDA Approved

Semaglutide

Semaglutide

"The peptide that reshaped obesity medicine."

Mechanism

GLP-1 receptor agonist — mimics the incretin hormone GLP-1 to slow gastric emptying, reduce appetite, and improve glycemic control via pancreatic beta-cell stimulation.

SubcutaneousOral
312 studies
Metabolic Health
Trending FDA Approved

Tirzepatide

Tirzepatide

"Next-generation dual-receptor agonist rewriting weight loss benchmarks."

Mechanism

Dual GIP/GLP-1 receptor agonist — simultaneously activates both incretin hormone receptors to produce additive metabolic effects exceeding GLP-1 agonism alone.

Subcutaneous
187 studies
Recovery
Trending Research Only

BPC-157

Body Protection Compound 157

"The body's own repair signal, amplified."

Mechanism

Upregulates growth hormone receptor expression, promotes angiogenesis, and modulates nitric oxide synthesis in damaged tissue.

SubcutaneousOralIntramuscular
48 studies
Recovery
Trending Research Only

TB-500

Thymosin Beta-4 Fragment

"Accelerated healing at the cellular level."

Mechanism

Actin-sequestering peptide that promotes cell migration, angiogenesis, and anti-inflammatory signaling through Tβ4 receptor pathways.

SubcutaneousIntramuscular
67 studies
Metabolic Health
Trending Research Only

CJC-1295

CJC-1295 (Growth Hormone Releasing Hormone Analog)

"Sustained growth hormone release without the physiological peak-and-crash."

Mechanism

GHRH analog with extended half-life via DAC technology — binds albumin to produce sustained GH pulse amplification across pituitary somatotrophs.

Subcutaneous
22 studies
200+
Peptides Documented
1,400+
Clinical Studies Referenced
47
Therapeutic Conditions
Weekly
Research Monitoring

Peptide Therapy Guides

Use the guide library for deeper context once you know the compound or clinical question you want to investigate.

Stay Current

The Peptide Research Digest

Weekly briefings on new clinical studies, peptide approvals, protocol updates, and emerging research — curated for practitioners and serious researchers.

No spam. Unsubscribe anytime. Privacy Policy